Celebrating 22,000 Successful Implementations of VersaWrap Hydrogel Sheet
Alafair Biosciences has reached an impressive milestone, having surpassed 22,000 successful implants of its flagship product, the VersaWrap Hydrogel Sheet. This achievement highlights the company's dedication to innovation and its positive influence on patient care. The latest data confirms this growth, demonstrating that Alafair Biosciences is continually advancing in the medical device arena.
A Revolutionary Approach to Tissue Protection
The VersaWrap product line features a unique formulation composed of hyaluronic acid and alginate hydrogel, which is designed to facilitate tissue gliding and prevent tethering. These key features significantly reduce the necessity for reoperations and ultimately lead to better patient outcomes. Alafair's VersaWrap Tendon Protector is a Class II medical device recognized by the FDA for its application on tendons and ligaments, while the VersaWrap Nerve Protector is cleared for use on peripheral nerves, including nerve roots. This approach distinguishes VersaWrap from its competitors, which often rely on collagen derived from animal or human sources.
Impact on Patient Recovery
The experiences of medical professionals who have utilized VersaWrap in their practices support its effectiveness in improving recovery experiences for patients. Dr. Walter Lin, a noted Plastic and Reconstructive Surgeon from The Buncke Clinic, shared insights on the benefits of VersaWrap. He noted that, "Post-operative scarring and adhesions between adjacent soft tissue structures create various challenges during recovery. Patients receiving the VersaWrap treatment exhibit enhanced soft tissue gliding, diminished inflammation, and reduced pain, which I believe aids in speeding up their recovery and resuming normal activities."
About Alafair Biosciences
Alafair Biosciences is a pioneering medical device company devoted to developing innovative products leveraging hydrogel technology. The company's mission is to transform surgical care with products designed to enhance soft tissue protection effectively and improve patient outcomes. Alafair’s products have been strategically distributed through a network of independent distributors throughout the United States, ensuring accessibility for healthcare providers and patients alike.
About VersaWrap Hydrogel Sheet
The VersaWrap Hydrogel Sheet consists of the VersaWrap Tendon Protector and the VersaWrap Nerve Protector, both FDA-cleared devices designed to provide a gelatinous encasement for surgical applications. This unique hydrogel technology allows for unhindered gliding of tissues while minimizing the risk of adhesive formations, ultimately elevating the standards of patient recovery and care.
Frequently Asked Questions
What is VersaWrap Hydrogel Sheet used for?
VersaWrap Hydrogel Sheet is designed to protect soft tissues during healing, preventing tethering and enhancing recovery for tendons, ligaments, and peripheral nerves.
How many implants of VersaWrap have been completed?
Alafair Biosciences has surpassed 22,000 successful implants of its VersaWrap Hydrogel technology.
What are the components of VersaWrap Hydrogel Sheet?
VersaWrap consists of hyaluronic acid and alginate, making it a unique alternative to collagen-based products.
Is VersaWrap FDA cleared?
Yes, both the VersaWrap Tendon Protector and VersaWrap Nerve Protector are FDA-cleared medical devices.
What is Alafair Biosciences' mission?
Alafair Biosciences aims to revolutionize surgical care through its innovative hydrogel technology and to enhance patient outcomes.
